Abstract:The adenosine triphosphate (ATP)-binding cassette efflux transporter G2 (ABCG2) was originally discovered in a multidrug-resistant breast cancer cell line. Studies in the past have expanded the understanding of its role in physiology, disease pathology and drug resistance. With a widely distributed expression across different cell types, ABCG2 plays a central role in ATP-dependent efflux of a vast range of endogenous and exogenous molecules, thereby maintaining cellular homeostasis and providing tissue protection against xenobiotic insults. However, ABCG2 expression is subjected to alterations under various pathophysiological conditions such as inflammation, infection, tissue injury, disease pathology and in response to xenobiotics and endobiotics. These changes may interfere with the bioavailability of therapeutic substrate drugs conferring drug resistance and in certain cases worsen the pathophysiological state aggravating its severity. Considering the crucial role of ABCG2 in normal physiology, therapeutic interventions directly targeting the transporter function may produce serious side effects. Therefore, modulation of transporter regulation instead of inhibiting the transporter itself will allow subtle changes in ABCG2 activity. This requires a thorough comprehension of diverse factors and complex signaling pathways (Kinases, Wnt/β-catenin, Sonic hedgehog) operating at multiple regulatory levels dictating ABCG2 expression and activity. This review features a background on the physiological role of transporter, factors that modulate ABCG2 levels and highlights various signaling pathways, molecular mechanisms and genetic polymorphisms in ABCG2 regulation. This understanding will aid in identifying potential molecular targets for therapeutic interventions to overcome ABCG2-mediated multidrug resistance (MDR) and to manage ABCG2-related pathophysiology.

ABCG2: a Potential Marker of Stem Cells and Novel Target in Stem Cell and Cancer Therapy.

The combination of stem cell markers CD133 and ABCG2 predicts relapse in stage I non-small cell lung carcinomas

Expression of Potential Cancer Stem Cell Marker ABCG2 is Associated with Malignant Behaviors of Hepatocellular Carcinoma

The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype

ABCG2 is Required for Self-Renewal and Chemoresistance of CD133-positive Human Colorectal Cancer Cells

[Expression of ATP-binding Cassette Transporter ABCG2 in Gastric Carcinoma and Its Significance].

ABCG2 Gene and ABCG2 Protein Expression in Colorectal Cancer-In Silico and Wet Analysis

The progress of ABCG2 in tumor of digestive system

ABCG2: determining its relevance in clinical drug resistance

ABCG2: structure, function and role in drug response

Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line.

Expression of the Stem Cell Marker ABCB5 in Normal and Tumor Tissues

Rationally Screened and Designed ABCG2-Binding Aptamers for Targeting Cancer Stem Cells and Reversing Multidrug Resistance

The role of ATP‐binding cassette subfamily G member 1 in tumor progression

Analysis of ABCG2 Expression and Side Population Identifies Intrinsic Drug Efflux in the HCC Cell Line MHCC-97L and Its Modulation by Akt Signaling.

Expression of ABCG2 in Human Liver Cancer Cell Lines and Its Related Functions

ABCG2 Regulated by MAPK Pathways is Associated with Cancer Progression in Laryngeal Squamous Cell Carcinoma.

ABCG2 Gene Expression in Non-Small Cell Lung Cancer

Multidrug efflux transporter ABCG2: expression and regulation

ABCG2 expression is related to low 5-ALA photodynamic diagnosis (PDD) efficacy and cancer stem cell phenotype, and suppression of ABCG2 improves the efficacy of PDD

Abnormal Wnt signaling and overexpression of ABCG2 contributes to drug efflux properties of side population cells in nasopharyngeal carcinoma